ARTICLE | Company News
CRXL licensing deal Selective Genetics
June 26, 2001 7:00 AM UTC
Tissue repair play Selective Genetics (San Diego, Calif.) received a non exclusive license to PER.C6 human cell line production technology from Crucell (CRXL; Euronext:CRXL). CRXL also will manufactur...